We are live on
!
Find out more
AA
AlphaCentric Advisors Portfolio holdings
AUM
$118M
This Fund
S&P 500
This Quarter
Est. Return
+7.21%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$166M
AUM Growth
+$16.8M
(+11%)
Cap. Flow
+$19.2M
Cap. Flow
% of AUM
11.58%
Top 10 Holdings %
Top 10 Hldgs %
22.19%
Holding
254
New
38
Increased
43
Reduced
118
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Therapeutics
UTHR
|
+$3.61M |
| 2 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
+$3.1M |
| 3 |
Axsome Therapeutics
AXSM
|
+$2.73M |
| 4 |
Pfizer
PFE
|
+$2.64M |
| 5 |
TRML
Tourmaline Bio
TRML
|
+$2.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IMGN
Immunogen Inc
IMGN
|
+$3.78M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$3.13M |
| 3 |
ABVX
Abivax
ABVX
|
+$2.86M |
| 4 |
Ironwood Pharmaceuticals
IRWD
|
+$2.8M |
| 5 |
Amylyx Pharmaceuticals
AMLX
|
+$2.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 61.45% |
| 2 | Real Estate | 11.2% |
| 3 | Financials | 4.6% |
| 4 | Industrials | 3.92% |
| 5 | Technology | 2.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Charter Communications
CHTR
$14.7B
| $70.3K | 0.04% |
242
-34
| -12% | -$10.9K |
|
202
Wynn Resorts
WYNN
$10.1B
| $68.7K | 0.04% |
672
-89
| -12% | -$8.83K |
|
203
Kinross Gold
KGC
$28.5B
| $67.6K | 0.04% |
11,022
-1,491
| -12% | -$8.11K |
|
204
Las Vegas Sands
LVS
$30.5B
| $61.6K | 0.04% |
1,191
-156
| -12% | -$8.03K |
|
205
NVIDIA
NVDA
$5.01T
| $61.4K | 0.04% |
680
-90
| -12% | -$6.52K |
|
206
BorgWarner
BWA
$13.2B
| $60.5K | 0.04% |
+1,742
| New | +$57K |
|
207
Snowflake
SNOW
$92.9B
| $60K | 0.04% |
371
-50
| -12% | -$9.7K |
|
208
GXO Logistics
GXO
$6.06B
| $58.3K | 0.04% |
1,084
-147
| -12% | -$7.95K |
|
|
ASXC
209
DELISTED
Asensus Surgical, Inc.
ASXC
| $57.5K | 0.03% |
250,000
-50,000
| -17% | -$14.5K |
|
|
VTYX
210
DELISTED
Ventyx Biosciences
VTYX
| $55K | 0.03% |
10,000
| – | – |
|
211
Warner Bros
WBD
$64.6B
| $47.3K | 0.03% |
5,421
-733
| -12% | -$7.06K |
|
212
DoorDash
DASH
$75.3B
| $45K | 0.03% |
327
-44
| -12% | -$5.18K |
|
213
CG Oncology
CGON
$6.11B
| $43.9K | 0.03% |
+1,000
| New | +$40.8K |
|
214
Trade Desk
TTD
$8.13B
| $40.8K | 0.02% |
467
-63
| -12% | -$4.77K |
|
|
SWAV
215
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $39.1K | 0.02% |
120
-16
| -12% | -$3.93K |
|
216
HubSpot
HUBS
$10.5B
| $37.6K | 0.02% |
60
-8
| -12% | -$4.81K |
|
217
Fortinet
FTNT
$112B
| $35.1K | 0.02% |
514
-69
| -12% | -$4.59K |
|
218
Sarepta Therapeutics
SRPT
$1.66B
| $34.8K | 0.02% |
269
-36
| -12% | -$4.41K |
|
219
Datadog
DDOG
$87.9B
| $33.5K | 0.02% |
271
-37
| -12% | -$4.65K |
|
220
MongoDB
MDB
$24B
| $33.4K | 0.02% |
93
-13
| -12% | -$5.31K |
|
|
CFLT
221
DELISTED
Confluent
CFLT
| $30.5K | 0.02% |
1,000
-135
| -12% | -$3.81K |
|
222
Zscaler
ZS
$23B
| $28.9K | 0.02% |
150
-20
| -12% | -$4.47K |
|
223
Phinia Inc
PHIN
$2.9B
| $13.6K | 0.01% |
353
-46
| -12% | -$1.5K |
|
|
ABVX
224
Abivax
ABVX
$11B
| – | – |
-267,500
| Closed | -$2.86M |
|
|
225
Amylyx Pharmaceuticals
AMLX
$2.05B
| – | – |
-151,000
| Closed | -$2.22M |
|
Similar funds
AIS
IVGAI
OIM
TIP
RCG
CWM
SPW
WLC
AlphaCentric Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, AlphaCentric Advisors held 254 positions worth $166M, up 11% from $149M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
AlphaCentric Advisors deployed $19.2M of net new capital in Q1 2024, opening 38 new positions and adding to 43 existing holdings. Its largest new stake was United Therapeutics: 16,000 shares worth $3.68M.
By sector, the portfolio is most concentrated in Healthcare at 61% of assets, up from 59% a quarter earlier, followed by Real Estate and Financials.
On the sell side, the largest reduction was Invesco NASDAQ 100 ETF, an estimated $1.72M trimmed.
- AlphaCentric Advisors's largest Q1 2024 buy was United Therapeutics: 16,000 shares worth $3.68M.
- AlphaCentric Advisors added most to Inari Medical, Inc. Common Stock in Q1 2024, an estimated $3.1M increase.
- AlphaCentric Advisors's biggest Q1 2024 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $1.72M.
- AlphaCentric Advisors fully exited Immunogen Inc in Q1 2024, selling an estimated $3.78M.
- AlphaCentric Advisors's ten largest holdings make up 22% of its $166M portfolio in Q1 2024.
- AlphaCentric Advisors opened 38 new positions and closed 26 in Q1 2024.
- AlphaCentric Advisors's portfolio value rose 11% quarter-over-quarter to $166M.
Based on AlphaCentric Advisors's 13F filing for Q1 2024, filed 24 Apr 2024.